Eric Pauwels, CEO: PTC Therapeutics PTCT Sell · Filed 25/02/21

Trade details

Type: Insider sale
Amount: $78,538.04
Shares · price: 1,567 sh · $50.12 a share
Held after: 83,860 sh
Stock: PTC Therapeutics PTCT
Person: Eric PauwelsCEO
Trade date: 25/02/20
Filed: 25/02/21
Days to filing: 1 days

Sold 1.8% of holdings

Share of holding sold: 1.8%

PTC Therapeutics trades, last 26 weeks

What else happened in PTC Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/21~25/03/22

Eric Pauwels's recent trades

Eric PauwelsChief Business Officer
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$1.3M
17,566 sh
$1.3M
Filed 06/12
Traded 06/10
Eric PauwelsChief Business Officer
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$278.3K
3,711 sh
$278.3K
Filed 06/12
Traded 06/10
Eric PauwelsChief Business Officer
Planned sale10b5-1 planPTC Therapeutics
Planned sale10b5-1 plan
PTC Therapeutics
PTCT
$1.6M
21,277 sh
$1.6M
Filed 06/10
Traded 06/10
Eric PauwelsChief Business Officer
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$209.4K
3,019 sh
$209.4K
Filed 02/20
Traded 02/18
Eric PauwelsChief Business Officer
Planned salePTC Therapeutics
Planned sale
PTC Therapeutics
PTCT
$209.4K
3,019 sh
$209.4K
Filed 02/18
Traded 02/18